Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 31, 2006
Rio™ Aspiration Catheter is indicated for use in the removal of thrombi, or clots, from vessels throughout the body
-
May 26, 2006
In upholding the trial court, the Court of Appeals agreed that Boston Scientific's products were not within the scope of the Medtronic patents
-
May 22, 2006
Researchers say novel visualization capability may reduce common need for repeat procedures
-
May 20, 2006
Trial advances understanding of dual-chamber pacing for patients at risk of sudden cardiac death
-
May 19, 2006
LATITUDE® Patient Management System aligns closely with recent ACC/AHA guidelines on managing heart failure
-
May 18, 2006
Physician society draft recommendations reinforce LATITUDE Active Monitoring ™ capabilities
-
May 18, 2006Boston Scientific to Release Broad Range of Clinical Results on Endoscopic Technologies at DDW® 2006
Physicians offer preview of SpyGlass™ Direct Visualization System
-
May 17, 2006
New second-generation training center in Brussels to help medical professionals advance standard of patient care
-
May 17, 2006TAXUS benefits demonstrated in non-diabetic patient population carry over into insulin-treated diabetic patients
TAXUS benefits demonstrated in non-diabetic patient population carry over into insulin-treated diabetic patients
-
May 16, 2006
TAXUS VI results support positive safety and efficacy profile
-
May 16, 2006
Boston Scientific's second generation stent compares favorably to market leading TAXUS Express2™ stent system, even with more complex lesions
-
May 16, 2006
Company made the announcement at the annual Paris Course on Revascularization (EuroPCR).
-
May 16, 2006Boston Scientific's second-generation stent system now approved for treatment of acute mycocardial infarction, total occlusions and in-stent restenosis
Boston Scientific's second-generation stent system now approved for treatment of acute mycocardial infarction, total occlusions and in-stent restenosis
-
May 15, 2006
Cardiac Rhythm Management (CRM) Group is formerly Guidant's CRM business; Boston Scientific acquired Guidant on April 21
-
May 11, 2006
Court also upheld its earlier decision dismissing the TAXUS® Liberte™ product from the case, without prejudice
-
May 11, 2006
Pending approval from the Board of Directors, Dr. Baim will also join Boston Scientific's Executive Committee
-
May 10, 2006
Boston Scientific is the exclusive U.S. distributor of this product for a new treatment option for female stress urinary incontinence
-
May 9, 2006
Results to include nine-month data on TAXUS® Liberte™
-
May 4, 2006
Lawsuit alleges that the Conor CoStar™ Paclitaxel-Eluting Coronary Stent System infringes a balloon catheter patent owned by Boston Scientific
-
May 3, 2006
Court finds Sahajanand's Infinnium paclitaxel-eluting stent infringed two claims of an Angiotech patent
-
May 1, 2006Endoscopic vessel harvesting speeds recovery and reduces pain and scarring; new products offer clinicians more choices to improve patient outcomes
Endoscopic vessel harvesting speeds recovery and reduces pain and scarring; new products offer clinicians more choices to improve patient outcomes
-
Apr 28, 2006
A live webcast and replay of the May 4 conference session will be available
-
Apr 28, 2006
A live webcast and replay of the May 2 conference session will be available
-
Apr 26, 2006
Includes recommendations for the surveillance, analysis and performance reporting of pacemakers and implantable cardioverter defibrillators (ICDs)
-
Apr 26, 2006
Both were members of the board of directors of Guidant Corporation, which was acquired by the Company last week